Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
AstraZeneca
Queensland Health
McKesson
Boehringer Ingelheim
Julphar
Fish and Richardson
Farmers Insurance

Generated: November 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: oritavancin diphosphate

« Back to Dashboard

oritavancin diphosphate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Melinta Therap ORBACTIV oritavancin diphosphate POWDER;INTRAVENOUS 206334 NDA The Medicines Company 65293-015-03 3 VIAL, GLASS in 1 CARTON (65293-015-03) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (65293-015-01)
Melinta Therap ORBACTIV oritavancin diphosphate POWDER;INTRAVENOUS 206334 NDA Melinta Therapeutics, Inc. 70842-140-03 3 VIAL, GLASS in 1 CARTON (70842-140-03) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKinsey
Moodys
Daiichi Sankyo
Express Scripts
McKesson
Argus Health
Fish and Richardson
US Department of Justice